BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Paola R, Cuzzocrea S. Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol 2007;375:157-75. [PMID: 17394034 DOI: 10.1007/s00210-007-0141-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Miglio G, Rosa AC, Rattazzi L, Grange C, Collino M, Camussi G, Fantozzi R. The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury. Br J Pharmacol 2011;162:111-25. [PMID: 20840470 DOI: 10.1111/j.1476-5381.2010.01032.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
2 Pang T, Kaufman A, Choi J, Gill A, Drummond M, Hugh T, Samra J. Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases. Mol Clin Oncol 2015;3:308-16. [PMID: 25798259 DOI: 10.3892/mco.2014.482] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
3 Kinsey GR, Okusa MD. Pathogenesis of acute kidney injury: foundation for clinical practice. Am J Kidney Dis 2011;58:291-301. [PMID: 21530035 DOI: 10.1053/j.ajkd.2011.02.385] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
4 Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007;376:1-43. [PMID: 18038125 DOI: 10.1007/s00210-007-0183-5] [Cited by in Crossref: 134] [Cited by in F6Publishing: 126] [Article Influence: 8.9] [Reference Citation Analysis]
5 Paterniti I, Esposito E, Mazzon E, Galuppo M, Di Paola R, Bramanti P, Kapoor A, Thiemermann C, Cuzzocrea S. Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury. J Pharmacol Exp Ther 2010;333:465-77. [DOI: 10.1124/jpet.110.165605] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
6 Gao Z, Li YH. Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury. PPAR Res 2012;2012:738785. [PMID: 23213319 DOI: 10.1155/2012/738785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
7 Lin CM, Tsai JT, Chang CK, Cheng JT, Lin JW. Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats. Drug Des Devel Ther 2015;9:4709-17. [PMID: 26316709 DOI: 10.2147/DDDT.S86616] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Chen HH, Chen TW, Lin H. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2009;297:F1109-18. [PMID: 19640904 DOI: 10.1152/ajprenal.00057.2009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
9 Zeng Y, Xie K, Dong H, Zhang H, Wang F, Li Y, Xiong L. Hyperbaric oxygen preconditioning protects cortical neurons against oxygen-glucose deprivation injury: role of peroxisome proliferator-activated receptor-gamma. Brain Res 2012;1452:140-50. [PMID: 22444276 DOI: 10.1016/j.brainres.2012.02.063] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
10 Wang C, Li Z, Zhao B, Wu Y, Fu Y, Kang K, Li Y, Dong L, Li X, Zhang B, Wu H, Shen B, Xu Y, Pan S, Jiang H, Wang D, Ma Y. PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production. Oxid Med Cell Longev 2021;2021:6677955. [PMID: 34104311 DOI: 10.1155/2021/6677955] [Reference Citation Analysis]
11 Luo Y, He Q, Kuang G, Jiang Q, Yang J. PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status. Behav Brain Funct 2014;10:21. [PMID: 24934302 DOI: 10.1186/1744-9081-10-21] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
12 Penson PE, Ford WR, Kidd EJ, Broadley KJ. Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol. 2008;378:589-597. [PMID: 18663429 DOI: 10.1007/s00210-008-0331-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Rodrigues WF, Miguel CB, Chica JE, Napimoga MH. 15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 2010;105:137-43. [PMID: 20428671 DOI: 10.1590/s0074-02762010000200005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tsai CC, Lee KS, Chen SH, Chen LJ, Liu KF, Cheng JT. Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury. PPAR Res 2014;2014:456386. [PMID: 24817882 DOI: 10.1155/2014/456386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
15 Liu YH, Lu M, Hu LF, Wong PT, Webb GD, Bian JS. Hydrogen sulfide in the mammalian cardiovascular system. Antioxid Redox Signal 2012;17:141-85. [PMID: 22304473 DOI: 10.1089/ars.2011.4005] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 16.6] [Reference Citation Analysis]
16 Chao X, Xiong C, Dong W, Qu Y, Ning W, Liu W, Han F, Ma Y, Wang R, Fei Z, Han H. Activation of Peroxisome Proliferator–activated Receptor β/δ Attenuates Acute Ischemic Stroke on Middle Cerebral Ischemia Occlusion in Rats. Journal of Stroke and Cerebrovascular Diseases 2014;23:1396-402. [DOI: 10.1016/j.jstrokecerebrovasdis.2013.11.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
17 Zhou H, Sun J, Zhong W, Pan X, Liu C, Cheng F, Wang P, Rao Z. Dexmedetomidine preconditioning alleviated murine liver ischemia and reperfusion injury by promoting macrophage M2 activation via PPARγ/STAT3 signaling. Int Immunopharmacol 2020;82:106363. [PMID: 32145512 DOI: 10.1016/j.intimp.2020.106363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Di Paola R, Crisafulli C, Mazzon E, Esposito E, Paterniti I, Galuppo M, Genovese T, Thiemermann C, Cuzzocrea S. GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice. Shock 2010;33:426-35. [PMID: 20407409 DOI: 10.1097/SHK.0b013e3181b8f2fb] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]